Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia

Journal of Reproductive Immunology

Volumn 59, Issue 2, 2003, Pages 277-294

  Deborde, S ^a   Schofield, J N ^a   Rademacher, T W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

GPI; GPI PLD; IPG; Placenta; Pre eclampsia

Indexed keywords

GLYCAN DERIVATIVE; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL SPECIFIC PHOSPHOLIPASE D; INOSITOL PHOSPHOGLYCAN; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

CAVEOLA; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLYCOGEN SYNTHESIS; HUMAN; HUMAN TISSUE; MICROENVIRONMENT; MICROVILLUS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN TRANSPORT; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0043244909     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(03)00054-8     Document Type: Conference Paper

References (46)

1. Adeniyi F.A., Olatunbosun D.A. Origins and significance of the increased plasma alkaline phosphatase during normal pregnancy and pre-eclampsia. Br. J. Obstet. Gynaecol. 91:1984;857-862.
2. Alvarez J.F., Varela I., Ruiz-Albusac J.M., Mato J.M. Localisation of the insulin-sensitive phosphatidylinositol glycan at the outer surface of the cell membrane. Biochem. Biophys. Res. Commun. 152:1988;1455-1462.
3. Anderson R.G. The caveolae membrane system. Annu. Rev. Biochem. 67:1998;199-225.
4. Arkwright P.D., Rademacher T.W., Dwek R.A., Redman C.W. Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles. J. Clin. Invest. 91:1993;2744-2753.
5. Benster B. Serum heat-stable alkaline phosphatase in pregnancy complicated by hypertension. J. Obstet. Gynaecol. Br. Commonw. 77:1970;990-993.
6. Broughton Pipkin F. Risk factors for pre-eclampsia. New Engl. J. Med. 344:2001;925-926.
7. Caro H.N., Kunjara S., Rademacher T.W., Leon L., Jones D.R., Avila M.A., Varela-Nieto I. Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver. Biochem. Mol. Med. 61:1997;214-228.
8. Civenni G., Butikofer P., Stadelmann B., Brodbeck U. In vitro phosphorylation of purified glycosylphosphatidylinositol-specific phospholipase D. Biol. Chem. 380:1999;585-588.
9. Deeg M.A., Bierman E.L., Cheung M.C. GPI-specific phospholipases D associates with an apoA-I- and apoA-IV-containing complex. J. Lipid Res. 42:2001;442-451.
10. Elased, K.M., Gumaa, K.A., de Souza, J.B., Playfair, J.H.L., Rademacher, T.W., 2003. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols (GPIs). Mol. Genet. Metab., in press.
11. Gaulton G.N. Differential regulation of glycosylated phosphatidylinositol subtypes by insulin. Diabetes. 40:1991;1297-1304.
12. Hari T., Butikofer P., Wiesmann U.N., Brodbeck U. Uptake and intracellular stability of glycosylphosphatidylinositol-specific phospholipase D in neuroblastoma cells. Biochim. Biophys. Acta. 1355:1997;293-302.
13. Heller M., Butikofer P., Brodbeck U. Generation by limited proteolysis of a catalytically active 39-kDa protein from the 115-kDa form of phosphatidylinositol-glycan-specific phospholipase D from bovine serum. Eur. J. Biochem. 224:1994;823-833.
14. Huang K.S., Li S., Fung W.J., Hulmes J.D., Reik L., Pan Y.C., Low M.G. Purification and characterization of glycosyl-phosphatidylinositol-specific phospholipase D. J. Biol. Chem. 265:1990;17738-17745.
15. Johansen M., Redman C.W., Wilkins T., Sargent I.L. Trophoblast deportation in human pregnancy - it's relevance for pre-eclampsia. Placenta. 20:1999;531-539.
16. Jones C.J., Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta. 1:1980;61-76.
17. Jones D.R., Varela-Nieto I. The role of glycosyl-phosphatidylinositol in signal transduction. Int. J. Cell Biol. 30:1998;313-326.
18. Jones C.J., Hartmann M., Blaschitz A., Desoye G. Ultrastructural localization of insulin receptors in human placenta. Am. J. Reprod. Immunol. 30:1993;136-145.
19. Jones D.R., Avila M.A., Sanz C., Varela-Nieto I. Glycosylphosphatidylinositol-phospholipase type D: a possible candidate for the generation of second messengers. Biochem. Biophys. Res. Commun. 233:1997;432-437.
20. Kunjara S., Wang D.Y., Greenbaum A.L., McLean P., Kurtz A., Rademacher T.W. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol. Genet. Metab. 68:1999;488-502.
21. Kunjara S., Greenbaum A.L., Wang D.Y., Caro H.N., McLean P., Redman C.W., Rademacher T.W. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol. Genet. Metab. 69:2000;144-158.
22. Leach R.E., Romero R., Kim Y.M., Chaiworapongsa T., Kilburn B., Das S.K., Dey S.K., Johnson A., Qureshi F., Jacques S., Armant D.R. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet. 360:2002;1215-1219.
23. Low M.G., Huang K.-S. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane abchors of cell surface proteins. Biochem. J. 279:1991;483-493.
24. Lyall F. The human placental bed revisited. Placenta. 23:2002;555-562.
25. Lyden T.W., Anderson C.L., Robinson J.M. The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae. Placenta. 23:2002;640-652.
26. Magpie Trial Collaborative Group, 2002. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial, Lancet 359, 1877-1890.
27. National High Blood Pressure Education Program, 1990. National high blood pressure education program working group report on high blood pressure in pregnancy, Am. J. Obstet. Gynecol. 163, 1691-1712.
28. Nelson D.M., Smith R.M., Jarett L. Nonuniform distribution and grouping of insulin receptors on the surfacre of human placental syncytial trophoblast. Diabetes. 27:1978;530-538.
29. Nestler J.E., Romero G., Huang L.C., Zhang C.G., Larner J. Insulin mediators are the signal transduction system responsible for insulin's actions on human placental steroidogensis. Endocrinology. 129:1991;2951-2956.
30. Parpal S., Gustavsson J., Stralfors P. Isolation of phosphooligosaccharide/phosphoinositol glycan from caveolae and cytosol of insulin-stimualted cells. J. Cell Biol. 131:1995;125-135.
31. Rademacher T.W., Caro H.N., Kunjara S., Wang D.Y., Greenbaum A.L., McLean P. Inositolphosphoglycan second messengers. Braz. J. Med. Biol. Res. 27:1994;327-341.
32. Redman C.W.G., Sargent I.L. Placental Debris, oxidative stress and pre-eclampsia. Placenta. 21:2000;597-602.
33. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Pre-eclampsia, an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204.
34. Robillard P.-Y., Dekker G.A., Hulsey T.C. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity. Eur. J. Obstet. Gynecol. Reprod. Biol. 84:1999;37-41.
35. Schofield J.N., Rademacher T.W. Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene. Biochim. Biophys. Acta. 1494:2000;189-194.
36. Schofield J.N., Stephens J.W., Hurel S.J., Bell K.M., deSouza J.B., Rademacher T.W. Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. Mol. Genet. Metab. 75:2002;154-161.
37. Shaskin P.N., Wasner H.K., Ortmeyer H.K., Hansen B.C. Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger of insulin action. Comparative analysis of two kinds of 'insulin mediators'. Diabetes Metab. Res. Rev. 17:2001;273-284.
38. Sleight S., Wilson B.A., Heimark D.B., Larner J. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles. Biochem. Biophys. Res. Commun. 295:2002;561-569.
39. Smith N.C., Brush M.G., Luckett S. Preparation of human placental villous surface membrane. Nature. 252:1974;302-303.
40. Suzuki S., Toyota T., Suzuki H., Goto Y. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase. Arch. Biochem. Biophys. 235:1984;418-426.
41. Villar A.V., Goni F.M., Alonso A., Jones D.R., Leon Y., Varela N.I. Phospholipase cleavage of glycosylphosphatidylinositol reconstituted in liposomal membranes. FEBS Lett. 432:1998;150-154.
42. Walker J.J. Pre-eclampsia. Lancet. 356:2000;1260-1265.
43. Wang J.X., Knottnerus A.-M., Schuit G., Norman R.J., Chan A., Dekker G.A. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet. 359:2002;673-674.
44. Whitsett J.A., Lessard J.L. Characteristics on the microvillous brush border of human placenta: insulin receptor localization in brush border membranes. Endocrinology. 103:1978;1458-1468.
45. Whitsett J.A., Johnson C.L., Hawkins K. Differences in localization of insulin receptors and adenylate cyclase in the human placenta. Am. J. Obstet. Gynecol. 133:1979;204-207.
46. Wimalasundera R.C., Larbalestier N., Smith J.H., de Ruiter A., McG Thom S.A., Hughes A.D., Poulter N., Regan L., Taylor G.P. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet. 360:2002;1152-1154.